Literature DB >> 2607519

Predicting acute gout in diuretic-treated hypertensive patients.

P C Waller1, L E Ramsay.   

Abstract

Factors predisposing to diuretic-induced acute gout were investigated in a case-control study. Seventy hypertensive patients with acute gout occurring during diuretic treatment were identified and matched for age and sex to 140 hypertensive controls who took diuretics but did not develop gout. Gout was related more strongly to the use of loop diuretics than thiazides, with 30% of cases taking a loop diuretic compared to 14% of controls (P less than 0.01). In a sub-group of men who took a thiazide and no other diuretic, gout was significantly associated with obesity (odds ratio 3.7, 95% confidence interval 1.4, 9.1) and high alcohol intake (odds ratio 3.3, 95% confidence interval 1.1, 9.8). In these patients, 23% of gout was attributable to obesity and 16% to high alcohol consumption. Approximately 40% of acute gout might have been prevented by avoiding thiazides in those 20% of men who weighed more than 90 kg and/or consumed more than 56 units of alcohol per week.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2607519

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  8 in total

Review 1.  Use of diuretics in cardiovascular diseases: (1) heart failure.

Authors:  S U Shah; S Anjum; W A Littler
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

2.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

3.  Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

Authors:  R D Feldman; N R Campbell; P Larochelle
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

4.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

5.  Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study.

Authors:  Mara A McAdams DeMarco; Janet W Maynard; Alan N Baer; Allan C Gelber; J Hunter Young; Alvaro Alonso; Josef Coresh
Journal:  Arthritis Rheum       Date:  2012-01

Review 6.  Use of febuxostat in the management of gout in the United Kingdom.

Authors:  Arabella Waller; Kelsey M Jordan
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-12-28       Impact factor: 5.346

7.  Managing hypertensive patients with gout who take thiazide.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-08       Impact factor: 3.738

Review 8.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.